Aside from Humana and Kaiser Permanente Ventures, Omada Health has scored yet another insurer investor: Cigna.
Omada, which has a built a digital platform to prevent prediabetics from becoming full-blown Type 2 diabetes patients, announced Wednesday that Cigna led its $50 million round that also attracted two new investors: Civilization Ventures and Sanofi Genzyme BioVentures.
Cigna is doing more than just investing in Omada. It is also expanding its commercial partnership with the San Francisco-based company such that the behavioral health technology will be made available to Cigna customers with prediabetes, as well as those at higher risk of chronic conditions such as heart disease and hypertension.
Read More: http://medcitynews.com/2017/06/cigna-leads-omada-healths-latest-50m-investment-round/
Via: MedCity News
Via: KING 5
Stroke prevention is all about catching a problem before it becomes life or death. Treatment usually involves angioplasty or a stent to increase blood flow in the arteries.
Now, a new procedure promises to lower the chance of stroke during surgery by redirecting and filtering blood.
Traditional surgeries to place a stent can pose the risk of what’s called a 'procedural stroke,' that's when doctors dislodge plaque from the arteries, and it gets into the brain. But Vascular surgeons at Virginia Mason have a new tool to protect from procedural stroke called trans carotid artery revascularization or TCAR.
Here's how it works - a specialized sheath, or tube, is placed in the common carotid artery which reverses the blood flow, directing it away from the brain. That blood then runs through a filter which catches any plaque loosened during the procedure. Finally, a stent is placed in the artery through the same sheath used to reverse blood flow.
Read More: www.king5.com/news/local/new-procedure-help-prevent-procedural-stroke-at-virginia-mason/447989054
Oxygen-rich blood generally flows from the heart to the brain, but a new technology aimed at preventing strokes temporarily reverses that path.
Outset Medical Sets Out To Upend Dialysis
BEND, Ore. - St. Charles Bend announced Monday it is the first hospital in Oregon to offer a new treatment program for patients at risk for stroke due to blockages in their neck arteries.
Q1 Cash Balance of $156.9M — Cash Through Q3 2019
Phase 1a Study Will Assess Novel Checkpoint Inhibitor as a Single Agent in Solid Tumors
Outset Medical announced it received $76.5 million in Series C equity funding. A new investor, funds advised by T. Rowe Price Associates Inc., led the round, which also included participation from existing investors Fidelity Management & Research Company, Partner Fund Management LP, Warburg Pincus, Perceptive Advisors and The Vertical Group.
Via: Business Wire
Financing to Expand U.S. Commercial Introduction and Manufacturing
Via: Huffington Post
I heard Omada Health president Sean Duffy on an April 13, 2017 NEJM Catalyst webinar reference the road by which non-pharmacological, integrative diabetes care gained coverage. Duffy, a “high tech high touch” Bay Area entrepreneur, displayed his literally out-of-the-box thinking elsewhere in the webinar when he urged the medical industry to “build a pervasive culture in which in-person visits are a last resort.” Might this interesting executive’s experience offer insights for those who realize that lack of coverage for non-pharmacologic, integrative pain treatment is a massive barrier to human health? I set up an interview.